Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alemtuzumab and rheumatoid arthritis immunisation study
2010-021146-22Phase 4Completed
- Sponsor
- Newcastle Hospitals NHS Foundation Trust
- Start
- Oct 2012
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of alemtuzumab in rheumatoid arthritis (RA) (2 arms), sponsored by Newcastle Hospitals NHS Foundation Trust. Started Oct 2012; status: completed.
02
Drugs
alemtuzumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2010-021146-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021146-22.